Live feed
Filing
SC 13G/A
SC 13G/A0001193125-21-037124·ASLAN Pharmaceuticals Ltd
Schedule 13G ownership disclosure
ASLAN PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 04522R101
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-037124
- Form type
- SC 13G/A
- Filer
- ASLAN Pharmaceuticals Ltd
- CIK
- CIK 1722926
- Filed
- Feb 11, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership